<DOC>
<DOCNO>
EP-0002066
</DOCNO>
<TEXT>
<DATE>
19790530
</DATE>
<IPC-CLASSIFICATIONS>
A61P-31/00 C07D-327/06 C07C-243/20 C07D-233/80 C07D-213/77 A61K-31/195 C07C-243/22 C07C-109/04 C07D-213/00 C07D-215/28 C07D-327/00 C07D-215/42 C07D-215/00 C07C-67/00 A61K-31/215 A61P-31/10 C07D-295/22 <main>A61K-31/15</main> C07C-243/00 A61K-31/445 A01N-45/00 A61P-31/04 C07D-233/00 C07D-295/00 A61K-31/185 C07C-241/00 A61P-31/12 C07D-295/30 C07C-109/00 A61K-31/15 A61K-31/21 
</IPC-CLASSIFICATIONS>
<TITLE>
2-adamantyl hydrazines and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
teva pharmail<sep>teva pharmaceutical industries limited<sep>teva pharmaceutical industries limitedhar hotzvim behind sanhedria ha'murhevetjerusalemil<sep>teva pharmaceutical industries limited<sep>
</APPLICANT>
<INVENTOR>
sterling jeffrey<sep>suchi raul<sep>weiner ben zion<sep>yellin haim<sep>sterling, jeffrey<sep>suchi, raul<sep>weiner, ben zion<sep>yellin, haim<sep>sterling, jeffrey126/14 maalot dafna streetjerusalemil<sep>suchi, raul10/2, giladi streetjerusalemil<sep>weiner, ben zion1, mevo livna streetjerusalemil<sep>yellin, haim46, hurgin streetramat ganil<sep>sterling, jeffrey<sep>suchi, raul<sep>weiner, ben zion<sep>yellin, haim<sep>sterling, jeffrey126/14 maalot dafna streetjerusalemil<sep>suchi, raul10/2, giladi streetjerusalemil<sep>weiner, ben zion1, mevo livna streetjerusalemil<sep>yellin, haim46, hurgin streetramat ganil<sep>
</INVENTOR>
<ABSTRACT>
the invention provides novel 2-adamantyl hydrazine  derivatives of the general formula a  in this formula r₁ is hydrogen or a lower alkyl group  of 1-4 carbon atoms; r₂ and r₃ are the same or different  and are each hydrogen, an unsubstituted or substituted  radical being a lower alkyl of 1-4 carbon atoms, a lower  alkanoic acid radical of 2-4 carbon atoms or a lower alkyl  ester thereof, adamantyl, aryl, aralkyl, in which the alkyl  moiety has from 1-4 carbon atoms or an unsubstituted or  substituted heterocyclic radical of aromatic character;  or r₂ and r₃ together with the nitrogen atom to which they  are attached form an unsubstituted or substituted non-aromatic  cyclic radical.  the invention further provides pharmaceutically acceptable  acid addition salts of the above compounds.  several methods of preparation of the new compounds  are described.  the novel compounds according to the invention  possess valuable antifungal (human and plant), antiviral,  antiprotozoal and antimicrobial properties.  
</ABSTRACT>
</TEXT>
</DOC>
